BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 28052221)

  • 21. Alendronate and fusion.
    Fehlings MG; Mobasheri R
    J Neurosurg Spine; 2011 Apr; 14(4):497-8; discussion 498-9. PubMed ID: 21275556
    [No Abstract]   [Full Text] [Related]  

  • 22. The costs and effectiveness of large Phase III pre-licensure vaccine clinical trials.
    Black S
    Expert Rev Vaccines; 2015; 14(12):1543-8. PubMed ID: 26414015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Medicines Company: an emerging pharmaceutical company in cardiology is spearheading an innovative approach to critical care medicines.
    Mayor S
    Eur Heart J; 2009 Jul; 30(13):1541-3. PubMed ID: 19579293
    [No Abstract]   [Full Text] [Related]  

  • 24. [Meta-analysis of alendronate preventing hip fracture risk of postmenopausal women].
    Yuan T; Li XL; Zhang CQ; Shi HP; Zeng BF
    Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1620-2. PubMed ID: 19957509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of alendronate in the treatment of the SAPHO syndrome.
    Fioravanti A; Cantarini L; Burroni L; Mazzei MA; Volterrani L; Galeazzi M
    J Clin Rheumatol; 2008 Jun; 14(3):183-4. PubMed ID: 18525442
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cost effective osteoporosis therapy. Alendronate is also immediately available as a generic drug].
    MMW Fortschr Med; 2005 Dec; 147(49-50):74-5. PubMed ID: 16401016
    [No Abstract]   [Full Text] [Related]  

  • 27. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis.
    Kishimoto M; Oishi A; Motojima S
    N Engl J Med; 2006 Nov; 355(20):2156; author reply 2157. PubMed ID: 17108350
    [No Abstract]   [Full Text] [Related]  

  • 28. [Diagnosis, clinical feature and treatment of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis].
    Nakayama H
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():499-503. PubMed ID: 18161156
    [No Abstract]   [Full Text] [Related]  

  • 29. [Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol].
    Ziegler R
    Med Monatsschr Pharm; 2007 Mar; 30(3):122-3. PubMed ID: 17405496
    [No Abstract]   [Full Text] [Related]  

  • 30. Use of generic alendronate in the treatment of osteoporosis.
    National Osteoporosis Foundation of South Africa
    S Afr Med J; 2006 Aug; 96(8):696-7. PubMed ID: 17019490
    [No Abstract]   [Full Text] [Related]  

  • 31. [Evidence of alendronate treatment for osteoporosis].
    Harada A
    Nihon Rinsho; 2007 Nov; 65 Suppl 9():337-43. PubMed ID: 18161127
    [No Abstract]   [Full Text] [Related]  

  • 32. Derisking Psychiatric Drug Development: The NIMH's Fast Fail Program, A Novel Precompetitive Model.
    Grabb MC; Cross AJ; Potter WZ; McCracken JT
    J Clin Psychopharmacol; 2016 Oct; 36(5):419-21. PubMed ID: 27404513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
    Rossi CM; Di Comite G
    N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
    [No Abstract]   [Full Text] [Related]  

  • 34. Alendronate for treatment of renal transplant patients with osteoporosis.
    Chong C
    Transplant Proc; 2005 Dec; 37(10):4639; author reply 4639. PubMed ID: 16387188
    [No Abstract]   [Full Text] [Related]  

  • 35. Generic alendronate in the treatment of osteoporosis.
    Kanfer I
    S Afr Med J; 2006 Oct; 96(10):1008-10. PubMed ID: 17164925
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effect of alendronate on glucocorticoid-induced osteoporosis].
    Zou X; Li Q; Shi C
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 34(6):563-5. PubMed ID: 19587443
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment trial of multicentric reticulohistiocytosis with a combination of predonisolone, methotrexate and alendronate.
    Satoh M; Oyama N; Yamada H; Nakamura K; Kaneko F
    J Dermatol; 2008 Mar; 35(3):168-71. PubMed ID: 18346261
    [No Abstract]   [Full Text] [Related]  

  • 38. Results of special studies with alendronate.
    McClung M
    Int J Clin Pract Suppl; 1999 Apr; 101():67-72. PubMed ID: 12669743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deal watch: Valuation benefits of structure-enabled drug discovery.
    Borshell N; Papp T; Congreve M
    Nat Rev Drug Discov; 2011 Mar; 10(3):166. PubMed ID: 21358725
    [No Abstract]   [Full Text] [Related]  

  • 40. Oral alendronate in osteogenesis imperfecta.
    Unal E; Abaci A; Bober E; Buyukgebiz A
    Indian Pediatr; 2005 Nov; 42(11):1158-60. PubMed ID: 16340059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.